AIDS-related primary central nervous system lymphoma: A Norwegian national survey 1989-2003

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Haldorsen, Ingfrid S ^a,b   Kråkenes, Jostein ^a,b   Goplen, Anne K ^c   Dunlop, Oona ^c   Mella, Olav ^a,b   Espeland, Ansgar ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STEROID; TOXOPLASMA GONDII VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS PATIENT; AUTOPSY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIFESPAN; MALE; NORWAY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; REVIEW; RISK REDUCTION; SURVIVAL TIME; TREATMENT RESPONSE; TREND STUDY; ARTICLE; B CELL LYMPHOMA; BRAIN; CENTRAL NERVOUS SYSTEM TUMOR; INCIDENCE; MIDDLE AGED; PATHOLOGY; REGISTER; RISK; TIME; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BRAIN; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; NORWAY; REGISTRIES; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 50649091852     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-225     Document Type: Review

References (25)

1. Kasamon YL Ambinder RF AIDS-related primary central nervous system lymphoma Hematology-Oncology Clinics of North America 2005, 19:665-687 10.1016/j.hoc.2005.05.004
2. Cingolani A Fratino L Scoppettuolo G Antinori A Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era J Neurovirol 2005, 11 Suppl 3:38-44 10.1080/13550280500511808 16540454
3. Goplen AK Dunlop O Liestol K Lingjaerde OC Bruun JN Maehlen J The impact of primary central nervous system lymphoma in AIDS patients: A population-based autopsy study from Oslo J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:351-354 9111477
4. Masliah E DeTeresa RM Mallory ME Hansen LA Changes in pathological findings at autopsy in AIDS cases for the last 15 years AIDS 2000, 14:69-74 10.1097/00002030-200001070-00008 10714569
5. Ammassari A Scoppettuolo G Murri R Pezzotti P Cingolani A Del Borgo C De Luca A Antinori A Ortona L Changing disease patterns in focal brain lesion-causing disorders in AIDS J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:365-371 9704942
6. Chamberlain MC Kormanik PA AIDS-related central nervous system lymphomas J Neuro-Oncol 1999, 43:269-276 10.1023/A:1006262720665
7. Skiest DJ Crosby C Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma AIDS 2003, 17:1787-1793 10.1097/00002030-200308150-00007 12891064
8. Newell ME Hoy JF Cooper SG DeGraaff B Grulich AE Bryant M Millar JL Brew BJ Quinn DI Human immunodeficiency virus-related primary central nervous system lymphoma: Factors influencing survival in 111 patients Cancer 2004, 100:2627-2636 10.1002/cncr.20300 15197806
9. Diamond C Taylor TH Aboumrad T Anton-Culver H Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Incidence, presentation, treatment, and survival Cancer 2006, 106:128-135 10.1002/cncr.21562 16329140
10. Kirk O Pedersen C Cozzi-Lepri A Antunes F Miller V Gatell JM Katlama C Lazzarin A Skinhoj P Barton SE Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001, 98:3406-3412 10.1182/blood.V98.12.3406 11719381
11. Wolf T Brodt HR Fichtlscherer S Mantzsch K Hoelzer D Helm EB Mitrou PS Chow KU Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma 2005, 46:207-215 10.1080/ 10428190400015733 15621803
12. Ammassari A Cingolani A Pezzotti P De Luca DA Murri R Giancola ML Larocca LM Antinori A AIDS-related focal brain lesions in the era of highly active antiretroviral therapy Neurology 2000, 55:1194-1200 11071499
13. Torre D Speranza F Martegani R Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection HIV Med 2005, 6:66-78 10.1111/j.1468-1293.2005.00268.x 15807712
14. Gates AE Kaplan LD AIDS malignancies in the era of highly active antiretroviral therapy Oncology 2002, 16:657-665 12108891
15. Cote TR Manns A Hardy CR Yellin FJ Hartge P Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group J Natl Cancer Inst 1996, 88:675-679 10.1093/jnci/88.10.675 8627644
16. Robotin MC Law MG Milliken S Goldstein D Garsia RJ Dolan GM Kaldor JM Grulich AE Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia HIV Med 2004, 5:377-384 10.1111/j.1468-1293.2004.00238.x 15369514
17. Conti S Masocco M Pezzotti P Toccaceli V Vichi M Boros S Urciuoli R Valdarchi C Rezza G Differential impact of combined antiretroviral therapy on the survival of italian patients with specific AIDS-defining illnesses J Acquir Immune Defic Syndr 2000, 25:451-458 10.1097/ 00042560-200012150-00011 11141245
18. Haldorsen IS Krossnes BK Aarseth JH Scheie D Johannesen TB Mella O Espeland A Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003: Time trends in a 15-year national survey Cancer 2007, 110:1803-1814 10.1002/cncr.22989 17721992
19. Aavitsland P Nilsen O Lystad A Anonymous reporting of HIV infection: An evaluation of the HIV/AIDS surveillance system in Norway 1983-2000 Eur J Epidemiol 2001, 17:479-489 10.1023/A:1013795920687 11855582
20. Ruiz A Post MJ Bundschu C Ganz WI Georgiou M Primary central nervous system lymphoma in patients with AIDS Neuroimaging Clin N Am 1997, 7:281-296 9113691
21. McGowan JP Shah S Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy AIDS 1998, 12:952-954 9631151
22. Mathews C Barba D Fullerton SC Early biopsy versus empiric treatment with delayed biopsy of non-responders in suspected HIV-associated cerebral toxoplasmosis: A decision analysis AIDS 1995, 9:1243-1250 8561977 10.1097/00002030-199511000-00005
23. Raez LE Patel P Feun L Restrepo A Raub WA Jr. Cassileth PA Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL) Crit Rev Oncog 1998, 9:199-208 10201628
24. Benson CA Kaplan JE Masur H Pau A Pharm AP Holmes KK Treating opportunistic infections among HIV-infected adults and adolescents. Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Disease Society of America. 2007 http://www.aidsinfo.nih.gov/guidelines/
25. Bakshi R Neuroimaging of HIV and AIDS related illnesses: A review Front Biosci 2004, 9:632-646 10.2741/1256 14766397